 Adjuvant chemotherapy high-grade osteosarcoma extremity results Multi-Institutional Osteosarcoma Study Multi-Institutional Osteosarcoma Study MIOS intensive multiagent adjuvant chemotherapy outcome patients nonmetastatic high-grade osteosarcoma extremity concurrent controls definitive surgery primary tumor patients adjuvant chemotherapy adjuvant treatment results trial indicate six-year event-free survival control group chemotherapy group Similar results patients randomization treatment arms protocol patients treatment survival advantage patients immediate adjuvant chemotherapy apparent analysis prognostic factors patients immediate adjuvant chemotherapy reveals elevation serum lactic dehydrogenase diagnosis factor predictive adverse outcome Location primary site tibia favorable prognosis authors natural history high-grade osteosarcoma extremity past decades administration immediate adjuvant chemotherapy significant favorable impact event-free survival patients